BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22035799)

  • 1. Disruption of Wnt planar cell polarity signaling by aberrant accumulation of the MetAP-2 substrate Rab37.
    Sundberg TB; Darricarrere N; Cirone P; Li X; McDonald L; Mei X; Westlake CJ; Slusarski DC; Beynon RJ; Crews CM
    Chem Biol; 2011 Oct; 18(10):1300-11. PubMed ID: 22035799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chemical and genetic approach to the mode of action of fumagillin.
    Zhang Y; Yeh JR; Mara A; Ju R; Hines JF; Cirone P; Griesbach HL; Schneider I; Slusarski DC; Holley SA; Crews CM
    Chem Biol; 2006 Sep; 13(9):1001-9. PubMed ID: 16984890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
    Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A noncanonical path to mechanism of action.
    Peterson RT
    Chem Biol; 2006 Sep; 13(9):924-6. PubMed ID: 16984880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases.
    Brdlik CM; Crews CM
    J Biol Chem; 2004 Mar; 279(10):9475-80. PubMed ID: 14676204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for planar cell polarity signaling in angiogenesis.
    Cirone P; Lin S; Griesbach HL; Zhang Y; Slusarski DC; Crews CM
    Angiogenesis; 2008; 11(4):347-60. PubMed ID: 18798004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
    Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
    Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2).
    Garrabrant T; Tuman RW; Ludovici D; Tominovich R; Simoneaux RL; Galemmo RA; Johnson DL
    Angiogenesis; 2004; 7(2):91-6. PubMed ID: 15516829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
    Klein CD; Folkers G
    Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gpr125 modulates Dishevelled distribution and planar cell polarity signaling.
    Li X; Roszko I; Sepich DS; Ni M; Hamm HE; Marlow FL; Solnica-Krezel L
    Development; 2013 Jul; 140(14):3028-39. PubMed ID: 23821037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis.
    Ehlers T; Furness S; Robinson TP; Zhong HA; Goldsmith D; Aribser J; Bowen JP
    Curr Top Med Chem; 2016; 16(13):1478-88. PubMed ID: 26369821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine aminopeptidase 2 is required for HSC initiation and proliferation.
    Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY
    Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours.
    Mauriz JL; Martín-Renedo J; García-Palomo A; Tuñón MJ; González-Gallego J
    Curr Drug Targets; 2010 Nov; 11(11):1439-57. PubMed ID: 20583970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
    Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
    J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
    Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
    Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsporidian methionine aminopeptidase type 2.
    Weiss LM; Costa SF; Zhang H
    J Eukaryot Microbiol; 2001; Suppl():88S-90S. PubMed ID: 11906093
    [No Abstract]   [Full Text] [Related]  

  • 17. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine aminopeptidases type I and type II are essential to control cell proliferation.
    Bernier SG; Taghizadeh N; Thompson CD; Westlin WF; Hannig G
    J Cell Biochem; 2005 Aug; 95(6):1191-203. PubMed ID: 15962312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest.
    Yeh JJ; Ju R; Brdlik CM; Zhang W; Zhang Y; Matyskiela ME; Shotwell JD; Crews CM
    Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10379-10384. PubMed ID: 16790550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planar cell polarity proteins differentially regulate extracellular matrix organization and assembly during zebrafish gastrulation.
    Dohn MR; Mundell NA; Sawyer LM; Dunlap JA; Jessen JR
    Dev Biol; 2013 Nov; 383(1):39-51. PubMed ID: 24021482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.